0001143313-24-000042.txt : 20240315
0001143313-24-000042.hdr.sgml : 20240315
20240315134355
ACCESSION NUMBER: 0001143313-24-000042
CONFORMED SUBMISSION TYPE: 25-NSE/A
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
EFFECTIVENESS DATE: 20240315
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Viveon Health Acquisition Corp.
CENTRAL INDEX KEY: 0001823857
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39827
FILM NUMBER: 24753768
BUSINESS ADDRESS:
STREET 1: 3480 PEACHTREE ROAD NE
STREET 2: 2ND FLOOR - SUITE #112
CITY: ATLANTA
STATE: GA
ZIP: 30326
BUSINESS PHONE: 4045797978
MAIL ADDRESS:
STREET 1: 3480 PEACHTREE ROAD NE
STREET 2: 2ND FLOOR - SUITE #112
CITY: ATLANTA
STATE: GA
ZIP: 30326
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NYSE AMERICAN LLC
CENTRAL INDEX KEY: 0001143313
ORGANIZATION NAME:
IRS NUMBER: 522127241
FILING VALUES:
FORM TYPE: 25-NSE/A
BUSINESS ADDRESS:
STREET 1: 11 Wall Street
CITY: New York
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-5414
MAIL ADDRESS:
STREET 1: 11 Wall Street
CITY: New York
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE MKT LLC
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE Amex
DATE OF NAME CHANGE: 20090402
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE Alternext US LLC
DATE OF NAME CHANGE: 20081009
25-NSE/A
1
primary_doc.xml
X0203
0001143313
NYSE AMERICAN LLC
0001823857
Viveon Health Acquisition Corp.
001-39827
3953 Holcomb Bridge Road, Suite 200
Norcross
GA
GEORGIA
30092
(404) 579-7978
Common Stock; Rights, each exchangeable into one-twentieth of a share of Common Stock; Units, each consisting of 1 share of common stock, 1 Warrant entitling the holder to purchase 1/2 of a share of common stock, and 1 right to receive 1/20 of a share of common stock
17 CFR 240.12d2-2(b)
Emily Fuhrman
Analyst, Regulation
2024-03-15
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE FILING IN ERROR OF A FORM 25 WITH RESPECT TO THE STATED SECURITIES
NYSE American LLC ("NYSE American" or the "Exchange") submitted a Form 25 (the "Original Form 25") on March 8, 2024 to notify the Securities and Exchange Commission (the "Commission") of its intention to remove the entire class of Units, each consisting of 1 share of common stock, 1 Warrant entitling the holder to purchase 1/2 of a share of common stock, and 1 right to receive 1/20 of a share of common stock, the Rights, each exchangeable into one-twentieth of a share of Common Stock, and the Common Stock (the "Securities") of Viveon Health Acquisition Corp. (the "Company") from listing and registration on the Exchange, pursuant to the provisions of Rule 12d2-2(b). The Exchange is now filing this Form 25/A to notify the Commission that the Original Form 25 was filed in error. The Company has an ongoing appeal with respect to the delisting of the Securities and the Securites remain listed on the Exchange pending completion of that appeal process. In the event that the Company's appeal is unsuccessful, the Exchange will at such time file a subsequent Form 25 to effectuate the removal of the Securities from listing and registration on the Exchange.